A new macromolecular antitumor antibiotic, C-1027, an acidic protein with a molecular weight of 15,000 daltons, was recently isolated from a culture filtrate of Streptomyces globisporus C-1027; the procedures for its isolation and purification, as well as the chemical and biological properties, of C-1027
were reported previously.1>2) Our data suggested C-1027 to be a chromoprotein composed of a protein moiety consisting of many hydrophobic and hydroxyamino acids and a nonprotein chromophoreextractable with organic solvents such as methanol. Antibiotic C-1027 exhibited inhibitory activity against a number of Gram-positive bacteria and against some strains of Gram-negative bacteria, and, fur- Abbreviations: HPLC, high-performance liquid chromatography; PTH, phenylthiohydantoin; TFA, trifluoroacetic acid; SDS, sodium dodecyl sulfate; PAGE, polyaerylamide gel electrophoresis.
but were different in their absorption spectra, with one of them showing an absorption shoulder between 340 and 360nm. The ultraviolet spectra properties ofC-1027 differed from those of C-1027-AG due to the presence of the chromophore in the former. Recently, we have reported that the chromophore obtained from C-1027 by ethyl acetate extraction caused single-strand scission in phage DNAwithout any requirement for a reducing agent, and double-strand breakage of genomic DNA in LI210 carcinoma cells.5) These results suggested that the biological activity of C-1027 might be due to its chromophore.
Weundertook the present study to establish the whole amino acid sequence of the protein moiety of C-1027, anticipating that the result would provide information regarding the structure and function relationship of this protein.
We describe in this paper the purification of antibiotic C-1027 and of its antagonist C-1027-AG, the preparation of enzyme fragments of the latter, and the determination of the primary structure of were of reagent grade.
Production and purification. The procedure for producing the two proteins by S. grobisporus C-1027 and for the bioassay were the same as those described in our previous paper.1] Highly purified antibiotic C-1027 and C-1027-AGwere obtained by a purification procedure that was an improvement over the previous one,2 '4) and this procedure is next described. The proteins precipitated by adding ammoniumsulfate (2.5 kg) to the broth filtrate (5 1) at 4°C were dissolved in water and dialyzed overnight against frequently changed water. The dialyzed proteins were applied to a DEAE (OH-form) cellulose column (30x6cm i.d.). After washing with water, the bound proteins were eluted with 0.1 m sodium chloride as the eluant. A gross separation into two components could be accomplished with this ion-exchange column chromatography. Further purification of the two proteins obtained was conducted by hydrophobic column chromatography on a butyl Toyopearl 650C (23 x 2.5cm i.d.) column that had been previously equilibrated with 1.5 m ammonium sulfate in 0.05m phosphate buffer (pH 7.0). The column was then washed with 1.2m ammoniumsulfate in 0.05m phosphate buffer (pH 7.0), and eluted with 1.0m ammonium sulfate in 0.05m phosphate buffer (pH 7.0). The fractions displaying the antimicrobial activity of antibiotic C-1027 were eluted first, followed by the protein fractions of C-1027-AG that had no antimicrobial activity. The dialyzed fractions containing each protein were applied to a Sephadex G-50 column (50x2.2cm i. Ether-5PW column (75 x 7.5 mmi.d.), elution being carried out with a linear gradient from 1.5m to 0m ammonium sulfate in a 0.1 m phosphate buffer (pH 7.0) at a flow rate of 0.8ml/min, and the eluate was monitored at 220nm.
Performic acid oxidation.^Prior to protease digestion, the native protein was oxidized with performic acid in order to cleave the intra-molecular disulfide bond. The C-1027-AG substance (about 500 jig) was dissolved in 50 /zl of freshly prepared performic acid (formic acid-hydroxyperoxide=19: 1, stood for 2hr at room temperature before use), and the solution was then kept at -5°C for 150min. Finally, the solution was diluted with lml of ice-cooled water and immediately lyophilized. column for 45min with a linear gradient of0.01 m sodium phosphate buffer containing 50% acetonitrile from 10%
to 100% (v/v) in the same buffer. The VYDAC218TP54 (C18) column was also used for the chymotrypsin digest, and the same conditions as those described for the lysylercdopeptidase digest were used. The fractionated peptides were manually collected by monitoring the absorbance at 210 and 280nm. The flow rate was l.O ml/min.
Amino acid analysis and sequence determination. The proteins and peptides were hydrolyzed in 6m HC1 containing 4% thioglycolic acid at 1 10°C for 22 hr in sealed tubes. The hydrolyzates were analyzed with a Hitachi 835 S-type amino acid analyzer. Cysteine was determined as cysteic acid after performic acid oxidation.6) The amino terminal sequences of the intact protein and fragment peptides obtained by protease digestion were determined with a 477A gas-phase automatic sequencer (Applied Biosystems Inc.). PTH-Amino acids were determined by reversed-phase HPLC (Applied Biosystems Inc., 120A) with a gradient system according to the reported method.7)
Carboxyl terminal identification with carboxypeptidase. The amino acid sequence of the carboxyl terminal region was analyzed by periodic monitoring of the amino acids liberated by carboxypeptidase P digestion as described by Yokoyama. 8) The performic acid-oxidized protein (210 fig) was dissolved in 80fA of a 0.1m citrate buffer (pH 3.8)
containing 8m urea, and incubated in 270//I of a 0.1m citrate buffer (pH 3.8) at 37°C at an enzyme to substrate ratio of 1 :40 (w/w). At 0, 5, 10, 20, 30 and 60min after the start of incubation, 50 fA of the solution was withdrawn, 5fA of sodium sulfosalicylate was added to it, and the mixture was then subjected to an amino acid analysis.
Nomenclature. All peptides are namedby using letters and numbers. Letters indicate the type of cleavage; LEP, A. lyticus lysytewtfopeptidase; V8, S. aureus protease V8; AspN, P. fragi mutant e^sfopeptidase AspN, CPase, P. janthinellum carboxypeptidase P; CTP, a-chymotrypsin. Numbers indicate the order of isolation of the peptides from C-1027-AG.
Results
Characterization of C-1027 and C-1027-AG The present preparation of C-1027 and C-1027-AG showed a single band on SDSPAGEin the presence of 2-mercaptoethanol, and a single symmetric peak by analytical HPLC on TSKgel G 2000SW under the conditions described previously.2) A typical analytical HPLC chromatogram from the TSKgel Ether-5PW column is shown in Fig. 1 . Elution was carried out with a salt gradient as described in Materials and Methods. C-1027 and C-1027-AG were eluted at retention times of 13.8 and 18.0min, respectively.
The cytotoxic activity of the highly purified C-1027 was higher than that reported previously, showing a 50% inhibitory concentration (IC50) of approximately 0.1 ng/ml against KB carcinoma cells; C-1027-AG showed no activity, even at 4jng/m\. The amino acid composition of C-1027-AG is given in Table I . The total number of amino a Values in parentheses are theoretical ones based on the sequence data. acid residues was calculated to be 110. C-1027-AG contained high proportions of hydroxy amino acids, i.e., serine and threonine, and hydrophobic amino acids, i.e., glycine, alanine and valine, but no methionine and tryptophan.
The values based on the amino acid analysis are in agreement with those determined from the amino acid sequence described later. Also, the minimum molecular Primary Structure of C-1027-AG weight calculated from the composition was TSKgel 2000SW. The amino terminal amino 10,500, a value dissimilar to that of 15,000 es-acid sequences of C-1027 and C-1027-AG timated by SDS-PAGE or gel filtration on were determined by a sequencer using the intact proteins. As shown in Table II , residues up to the 20th from the amino terminus were clearly sequenced at the pmol level. In addition, C-1027-AG could be sequenced up to the 35th residue (Table III-l) . Carboxypeptidase P digestion of the performic acidoxidized C-1027-AG released the four carboxyl terminal amino acids, Gly, Phe, Thr and Leu, in that order, as shown in Fig. 2 . Accordingly, the carboxyl terminal sequence was deduced to be Leu-Thr-Phe-GlyOH.
Enzymatic digestion of C-1027-AG and the sequence analysis of the resultant peptides
The.elution profile from the VYDAC 218TP54 (C18) column ofa digest obtained by treating the performic acid-oxidized protein with lysylefldopeptidase is shown in Fig. 3 . The amino acid composition of the LEP-1 peptide thus obtained is shown in Table I . The digest gave one major peak by HPLC; the resulting peptide, consisting of 41 residues, was then directly sequenced with an automatic sequencer. These sequence data are summarized in Tables III-l and III-2. Peptide LEP-1, which contained no lysine residues, was finally identified as the carboxy terminal peptide chain composed of residues 70 to HO.These data support our conclusion that the amino acid sequence of the carboxyl terminus of the intact protein is Leu-Thr-Phe-GlyOH. Some of the peptides generated by the enzymic digestion were probably not eluted from the column under the conditions used. To obtain overlapping peptides and to confirm the sequence of the LEP-1 peptide, we performed a further digestion of the lysylercdopeptidase-digested performic acid-oxidized protein with protease V8, which is active towards Glu-and Asp-residues.
The resultant peptides were separated by HPLC on an Asahipak ODP-5 column. The elution profile and amino acid composition of the LEP-V8peptides are shown The same conditions as these described in Fig. 3 were used.
in Fig. 4 and in Table I , respectively. The eluate monitored at 210nm was divided into 8
fractions, and some of the fractions contained major peptides (LEP-V8-1, -4, -6 and -7), which were isolated as chromatographically pure substances. Among these peptides, LEP-V8-1 and -6, which constituted lysyk^Jopeptidase peptide LEP-1 , were determined by their amino acid compositions (Table I ) and were placed atpositions 70 to 77 and 78 to 1 10, respectively. Peptide LEP-V8-4 was first sequenced directly and determined up to the 29th residue from its amino terminus, as shown in Table III -l. The amino terminal sequence of this peptide is in good accordance with that determined by using intact C-1027-AG. Likewise, the amino acid sequence of the LEP-V8-7 peptide was analyzed up to the 37th residue. However, the last three residues from positions 38 to 40, corresponding to the carboxyl terminal region of this fragment, remain to be clarified. Based on the amino acid composition of LEP-V8-7, it contained one lysine residue was shown in Table I . The lysine residue must be at the carboxyl terminus of this peptide, as judged from the specificity of lysyleftdopeptidase. To establish the complete sequence, LEP-V8-7
peptide was further digested with endopeptidase AspN, which is active toward a peptide bond involving the amino group of the aspartyl residue. The resultant peptides were separated and purified to homogeneity by HPLC (Fig. Fig. 6 . Separation of the Chymotrypsin Digest of Intact C-1027-AG by Reversed-phase HPLC.
A 20fi\ sample of the digest was applied to a VYDAC 218TP54 (C18) column (250x4.6mm i.d.) at a flow rate of l.Oml/min. For the other conditions, see Materials and Methods. a Values in parentheses are theoretical ones based on the sequence data.
5), and their amino acid sequence were then determined. Through this experiment, protein fragment LEP-V8-7-AspN-4, corresponding to the unidentified region of LEP-V8-7, was obtained (Table III-2) . This peptide was at positions 56 to 69. To obtain further overlaps, the performic acid-oxidized C-1027-AG was digested with chymotrypsin. The digest was resolved into nine major peaks by HPLCon the VYDAC218TP54 (C18) column, as shown in Fig. 6 . From the amino acid composition (Table IV) , the peptides from CTP-1 to CTP-5 were assigned residue 108 to 110, 54 to 63, 64 to 71, 33 to 53, and 32 to 53, respectively. Peptide CTP-1 corresponded to the carboxyl terminal sequence. The amino acid sequence of CTP-3 was determined from the composition shown in Table IV , the overlapping peptide between peptide LEP-V8-7-AspN-4 and LEP-V8-1 being established. Consequently, the alignment of whole C- Horizontal arrows ( *) below the residues indicate that the sequences were determined by an Edmandegradation. Vertical lines represent the beginning and the end of the lysykrcdopeptidase (LEP), V.8 protease (V8), ercdcpeptidase AspN (AspN) and chymotrypsin (CTP) peptides. Dotted arrows ( aef)indicate cysteine residues not identified as PTHamino acids. The peptides, for which the actual lengths are not known, are indicated by a dashed line, and they do not have a vertical line at the carboxyl terminal end. The carboxyl terminal residues with arrows to the left (« ) were identified by carboxypeptidase P digestion (CPase).
V8-7-LEP-V8-1-LEP-V8-6. Based on the results already mentioned, the complete amino acid sequence of C-1027-AG is given in Fig.  7 , together with sequencing data for each isolated peptide.
In the present study, four half-cystine residues at positions 36, 45, 86 and 91 were found in C-1027-AG. To confirm the position of the disumde bridges in C-1027-AG, the intact protein was digested with chymotrypsin in a 0.2m pyridine-acetic acid buffer (pH 6.5) to yield cystine peptides suitable for a structural investigation.
The lyophilized material was subjected to HPLC. The cystine peptides eluted by HPLC were detected by reacting with 5,5/-dithiobis(2-nitrobenzoate) after reducing with sodium borohydride.9)
Two cystinecontaining peptides, termed fragments 19 and 22, were isolated, and their amino acid sequences were deduced to be from Ile(33) to Phe(53) and from Thr(72) to Ala(95), respectively, based on their amino acid compositions. Accordingly, one of the disulfide bridges was found to be located between Cys(36) and Cys(45) , and the other between Cys(86) and Cys(91). These positions for the disulfide bonds of the cystine residues thus result in two small loops of.10 and 6 amino acids, respectively.
Discussion
The amino acid sequence of C-1027-AG, a selective antagonist of newantitumor protein antibiotic C-1027 isolated from S. globisporus C-1027 was determined on the basis of peptides obtained by performic acid-oxidation and by proteolysis with enzymes. The amino acid sequencing of C-1027-AG following reduction and S-alkylation was not successful in this case. Virtually all the amino acid residues were specified by means of an Edman degradation in an automated sequencer, which was followed by the identification of PTHamino acid derivatives by HPLC. C-1027-AG consisted ofa total of 110 amino acid residues with an amino terminal alanine residue, a carboxyl terminal glycine residue, and 4 half-cysteines in two disulfide linkages. The molecular weight was therefore calculated to be 10,500 daltons. As reported in our first study,2) antibiotic C-1027 was found to consist of two components, a protein moiety and a very labile nonprotein chromophore extractable with such organic solvents as methanol. All the biological activity ofC-1027 was reported to be associated with the non-protein chromophore, while C-1027-AG did not show any antimicrobial or antitumor activity, although it decreased the C-1027-induced inhibition of bacterial growth.4'5) Also, it has been reported that the biological activities of C-1027 were reduced by UV-irradiation.
2) The UVabsorption spectrum of UV-irradiated C-1027 was found to be similar to that of C-1027-AG as a result of a decrease in the height of the definite absorption shoulder between 340 and 360nm. In the case ofC-1027-AG, no such alteration was detected. Moreover, C-1027 and its antagonistic protein, C-1027-AG, were described to be proteins of similar molecular weight, isoelectric point, and amino acid composition. The relationship between C-1027 and C-1027-AG, therefore, might be similar to that between other chromophore-containing antitumor proteins such as neocarzinostatin, auromomycin and macromomycin,and their apoproteins. As shown in this paper, the sequence analysis up to the 20th residue from the amino terminus of intact C-1027-AG and C-1027 agreed well between the two proteins. Recently, to clarify the role of the protein moiety, we have investigated a variety of proteolytic activitiesof C-1027 and C-1027-AG, as reported specific aminopeptidase activity for another antitumor antibiotic, macromomycin.10) Both proteins displayed proteolytic activity, while the chromophore fraction, which displayed the antimicrobial and antitumor activity, did not show any such activity. These results indicate that the primary structure of C-1027-AG is identical to that of the protein moiety of antibiotic C-1027. Some of the cytotoxic effects produced by C-1027 maybe related to the proteolytic activity seen in the proteinmoiety ofC-1027 or C-1027-AG. On the other hand, it will be of interest to determine the complete structure of the associated chromophore of C-1027, as well as that of the chromophore of neocarzinostatin and of auromomycin, because the chromophore in these molecules is involved in the mechanism responsible for their biological activity.11} Information obtained from our present results should contribute to a better understanding of the mechanism by which these apoproteins stabilize the chromophore and promote its interaction with DNA,as has been noted in the case ofneocarzinostatin1 1>12) and auromomycin.13) The similarities in physico-chemical characteristics and biological properties indicate that all of these chromophore-containing antitumor proteins are probably similar in their mechanism of action. Because of the similarity of sequence observed in the primary structure of these antitumor protein antibiotics, these homologous regions of the molecule may be involved in the mechanism by which these proteins carry out their biological functions. So far, the amino acid sequences of several similar antitumor proteins, e.g., neocarzinostatin,14) macromomycin15) and actinoxantin, 16) have been elucidated. The primary structure of C-1027-AG, and also ofC-1027, displays a high degree of homology with the protein moiety of these antitumor proteins. Acomparison of the structures of all of these antibiotics suggests that they belong to a family of related proteins produced by the Streptomyces species. In recent years, protein sequences have been used to estimated the evolutionary rate and phylogenetic relationships among different species at the molecular level, as was pointed out by Gibson et al.1^and Samy et al.15) The disparity present in the sequence homology between C-1027 and its three relatives, neocarzinostatin, macromomycinand actinoxantin, could have resulted from their evolutionary divergence. Since the amino acid sequence of the protein moiety of C-1027 has been determined, it seems possible to clone the protein gene, and thereby to study its structure 417 and the mechanism controlling its expression. Weare nowattempting to verify the amino acid sequence from nucleotide sequencing of the gene from S. globisporus C-1027.
